Clinical Trial Update: ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating alpha-linolenic acid-enriched nutrition to prevent cognitive decline in APOE4 older adults. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Michal Schnaider Beeri, Ph.D. | Conditions: Cognitive Dysfunction, Alzheimer Disease | Phase 2 | Status: RECRUITING